Each day I go on Barchart and sort the new high and new low list for frequency. I then take the top 10 highs and the top 10 lows and do additional screening. I'll list here those that pass and might be good additions to your portfolio. Use this list as a starting point and then investigate each stock to see if it has a place in your portfolio.
PTIE - Pain Therapeutics - 100% buy - 13 of 20 days of price appreciation and monthly return of 16.17%
Pain Therapeutics is developing a new generation of opioid painkillers.Opioids are drugs derived from the poppy plant. The company uses technology to reformulate opioid drugs, such as morphine, into new painkillers with improved clinical benefits. The company has four opioid painkillers in Phase II clinical trials. The company believes its drugs offer enhanced pain relief, fewer adverse side effects and reduced tolerance and addiction compared to existing opioid painkillers.
MEND - Micrus Endovascular - 100% buy - 10 of 20 days of price appreciation and a monthly return of 25.18%
Micrus Endovascular Corporation is a medical device company that develops, manufactures and markets implantable and disposable medical devices used in the treatment of cerebral vascular diseases.
XCHO - XenaCare Holdings - 100% buy - 13 of 20 days of price appreciation and a monthly return of 451.72%
XenaCare Holdings, Inc. engages in the formulation, marketing, and distribution of nutrition supplement products primarily in the United States. Its clinical products include XenaCor, which lowers serum cholesterol, C-reactive protein, and homocysteine levels, designed to support cardiovascular health; XenaTri for lowering triglycerides and raising HDL to support cardiovascular health; and XenaZyme Plus that increases the body's oxygen carrying capacities, designed to support digestion. The company's clinical products also comprise body replenishment products. In addition, it offers formulations for the energy/lifestyle performance market, which consists of sports line for athletes, including SunPill that is formulated to protect the skin when exposed to damaging ultraviolet rays. XenaCare markets its products through the Internet, pharmacies, infomercials, and doctors' offices
REGN - Regeneron Pharma - 100% buy - 12 of 20 days of price appreciation with a 19.42% return
Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic drugs for thetreatment of serious medical conditions. Regeneron's platform technologies include Targeted GenomicsTM, FunctionomicsTM, and Designer Protein TherapeuticsTM. Regeneron has drugs in clinical and preclinical development for the potential treatment of obesity, rheumatoid arthritis, cancer, allergies, asthma, amyotrophic lateral sclerosis, constipating conditions, ischemia, and other diseases and disorders.
SGB - SouthWest Georgia - 100% buy - 13 days of price appreciation in the last 20 sessions and a 52.48% return
Southwest Georgia Financial Corporation is a state-chartered bank holding company with approximately $290 million in assets headquartered in Moultrie, Georgia. Its primary subsidiary, Southwest Georgia Bank, offers comprehensive financial services to consumer, business, and governmental customers. The current banking facilities include the main office located in Colquitt County, and branch offices located in Baker County, Thomas County, and Worth County. In addition to conventional banking services, the bank provides investment planning and management, trust management, mortgage banking, and commercial and individual insurance products. Insurance products and advice are provided by Southwest Georgia Insurance Services which has an office in Colquitt County. Mortgage banking for primarily commercial properties is provided by Empire Financial Services, Inc., a mortgage banking services firm.
Sell or Short Stocks:
PKY - Parkway Properties - 100% sell with 13 price declines in the last 20 sessions and a 22.92% decline in price
Parkway Properties, Inc. is a self-administered, self-managed real estate investment trust specializing in the acquisition, ownership, management,financing and leasing of office properties in the Southeastern United States and Texas.
BSX - Boston Scientific - 100% sell rating with 11 price declines in 20 sessions and a 19.15% price decline
Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.
Please remember to research these stocks fully before adding to your portfolio
Jim Van Meerten is an investor who writes on financial matters here and on Financial Tides. Please leave a comment below or email JimVanMeerten@gmail.com
Disclosure: No positions at time of publication